97 related articles for article (PubMed ID: 577427)
21. [Pharmacological, pharmacokinetic and toxicological research on mesoridazine (NC 123)].
Loew DM; Grauwiler J; Griffith R; Taeschler M; Weidmann H; Zehnder K
Boll Chim Farm; 1967 May; 106(5):332-71. PubMed ID: 4890002
[No Abstract] [Full Text] [Related]
22. General pharmacological properties of muroctasin.
Kojima H; Hirohashi M; Kasai Y; Takasuna K; Fukumoto C; Akashi A
Arzneimittelforschung; 1988 Jul; 38(7A):1002-9. PubMed ID: 3190791
[TBL] [Abstract][Full Text] [Related]
23. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs.
Hirotsu I; Kihara T; Hattori Y; Hatta M; Hirose N; Ishihara T; Satoh F
Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381
[TBL] [Abstract][Full Text] [Related]
24. General pharmacology of a new analgesic-AP-237.
Carrano RA; Kimura KK; Landes RC; McCurdy DH
Arch Int Pharmacodyn Ther; 1975 Jan; 213(1):28-40. PubMed ID: 1156016
[TBL] [Abstract][Full Text] [Related]
25. General pharmacology of nizatidine in animals.
Bemis K; Bendele A; Clemens J; Deldar A; Gidda J; Hamelink J; Holland D; Lamishaw B; McGrath J; Shannon H
Arzneimittelforschung; 1989 Feb; 39(2):240-50. PubMed ID: 2567169
[TBL] [Abstract][Full Text] [Related]
26. [Pharmacological properties of the new neuroleptic of the phenothiazine series--dixyrazine].
Mikhaĭlova TV; Terekhina AI; Gilev AP
Farmakol Toksikol; 1969; 32(1):28-31. PubMed ID: 4388895
[No Abstract] [Full Text] [Related]
27. Pharmacological profile of the novel antidepressant 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno-[2,3-d]pyrimidine monohydrate hydrochloride.
Eguchi J; Inomata Y; Yuasa T; Egawa M; Saito K
Arzneimittelforschung; 1997 Dec; 47(12):1337-47. PubMed ID: 9450161
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacological studies of a new antitussive, 1-phenethyl-4-hydroxy-salicylamido-4-methyl-piperidine-hydrochloride (S 1592) (author's transl)].
Duhault J; Tisserand F; Regnier G
Arzneimittelforschung; 1976 Apr; 26(4):516-23. PubMed ID: 989005
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and pharmacological activity of befuraline (N-benzo[b]furan-2-ylcarbonyl-N'-benzylpiperazine), a new antidepressant compound.
Boksay IJ; Popendiker K; Weber RO; Söder A
Arzneimittelforschung; 1979; 29(2):193-204. PubMed ID: 582130
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacological studies on psychotropic drugs especially the effects of thiothixene].
Shibuya T; Horibe M; Sasaki Y; Matsuda H; Matsumiya T
Zasshi Tokyo Ika Daigaku; 1969 Nov; 27(6):839-57. PubMed ID: 4396402
[No Abstract] [Full Text] [Related]
31. Pharmacological profile of AD-5423, a novel antipsychotic with both potent dopamine-D2 and serotonin-S2 antagonist properties.
Oka M; Noda Y; Ochi Y; Furukawa K; Une T; Kurumiya S; Hino K; Karasawa T
J Pharmacol Exp Ther; 1993 Jan; 264(1):158-65. PubMed ID: 8093723
[TBL] [Abstract][Full Text] [Related]
32. On the central antiserotonin action of trazodone.
Baran L; Maj J; Rogóz Z; Skuza G
Pol J Pharmacol Pharm; 1979; 31(1):25-33. PubMed ID: 482164
[TBL] [Abstract][Full Text] [Related]
33. [Pharmacodynamics of alizapride (author's transl)].
Laville C; Margarit J
Sem Hop; 1982 Feb; 58(6):323-31. PubMed ID: 6280297
[TBL] [Abstract][Full Text] [Related]
34. General pharmacology of recombinant human basic fibroblast growth factor.
Okumura M; Yajima M; Nishimura T; Ikeda H; Nishimori T
Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346
[TBL] [Abstract][Full Text] [Related]
35. General pharmacology of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride. Effects on cardiovascular, visceral and renal functions and on hemodynamics.
Yamamoto S; Takemori E; Hasegawa Y; Kuroda K; Nakao K; Inukai T; Sakonjyo H; Nishimura T; Nishimori T
Arzneimittelforschung; 1991 Sep; 41(9):913-23. PubMed ID: 1796919
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological activities and side effects of plafibride.
Gras J; Basi N; Zapatero J; Bermejo P; Gimenez F; Beascoa E; Llenas J; Bargalló MA; Giráldez A; Bruseghini L
Arzneimittelforschung; 1981; 31(10a):1808-16. PubMed ID: 6976173
[TBL] [Abstract][Full Text] [Related]
37. The general pharmacology of a novel antitussive compound RU 20201.
Pickering RW; James GW
Arzneimittelforschung; 1979; 29(4):642-6. PubMed ID: 314807
[TBL] [Abstract][Full Text] [Related]
38. [Some pharmacodynamical properties of niaprazine, a new antihistaminic agent].
Duchene-Marullaz P; Rispat G; Perriere JP; Hache J; Labrid C
Therapie; 1971; 26(6):1203-9. PubMed ID: 4401719
[No Abstract] [Full Text] [Related]
39. General pharmacological properties of a new non-opiate antitussive: zipeprol (3024 CERM). II. Actions on the cardiovascular system, intestinal transit and central nervous system.
Cosnier D; Hache J; Labrid C; Rispat G
Arzneimittelforschung; 1976; 26(5):848-55. PubMed ID: 989357
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological studies on ticlopidine, a new platelet aggregation inhibitor. Part II: General pharmacological properties.
Akashi A; Hashizume T; Tanaka M; Naka S; Hirohashi M; Kasai Y; Sakurai T; Watanabe K; Tsubokawa M; Kasahara A
Arzneimittelforschung; 1980; 30(3):415-9. PubMed ID: 7387751
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
